United States · FDA National Drug Code directory
Cholestyramine Light
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51224-009_fb8b0e9c-1750-4016-95c7-d7a49e09d463
- Product NDC
- 51224-009
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cholestyramine
- Labeler
- TAGI Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201112 / 20270131
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/4.8g
These values do not establish equivalence or a dose recommendation.
Packages
- 201.6 g in 1 CAN (51224-009-10) · 51224-009-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →